Author:
Ferrari Michel Dominique,Ensink Franz Bernhard M.
Publisher
Springer Berlin Heidelberg
Reference47 articles.
1. Anthony M (1986) The biochemistry of migraine. In: Vinken PJ, Bmyn GW, Klawans HL, Clifford Rose F (eds) Headache. (Handbook of clinical neurology, vol 4 [48]). Elsevier Science, Amsterdam New York, pp 85–105
2. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563–576
3. Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB (1988) Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol 94: 397–412
4. Couturier EGM, Hering R, Foster CA, Steiner TJ, Clifford Rose F (1991) First clinical study of the selective 5-HT3 antagonist, granisetron (BRL 43694), in the acute treatment of migraine headache. Headache 31: 296–297
5. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990) Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322: 810–816